Announced
Completed
Synopsis
Investment companies Novo, General Atlantic and Goldman Sachs Asset Management led a Series C round in LePure Biotech, a biopharma solutions provider, with participation from Highlight Capital, Bayland Capital and HM Capital. Financial terms were not disclosed. LePure plans on using this funding to accelerate product innovation, promote overseas expansion, and enhance the Company’s competitiveness and influence in the global industrial chain.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.